FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

33767211000001103: Rupatadine 10mg tablets (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Feb 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
102666501000001110 Rupatadine 10mg tablets (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
102666601000001114 Rupatadine 10mg tablets (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rupatadine 10mg tablets (Aspire Pharma Ltd) Has specific active ingredient Rupatadine fumarate true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) Is a Rupatadine 10mg tablets true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) Has specific active ingredient Rupatadine fumarate false Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rupatadine false Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) Has basis of strength substance Rupatadine true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) Has active ingredient Substance with histamine receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets Has AMP True Rupatadine 10mg tablets (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start